GlobeNewsWire
13 Sept 2026, 04:24 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
A class action lawsuit alleges that Unicycive Therapeutics' regulatory approval of oxylanthanum carbonate (OLC) was likely delayed due to undisclosed manufacturing vendor deficiencies. — Delays in regulatory approval for a primary product candidate directly threaten a biotech company's revenue timeline and valuation.
-0.60The lawsuit claims Unicycive failed to inspect its third-party manufacturing vendor's facility or audit its compliance with current good manufacturing practices. — Operational negligence regarding FDA compliance increases the risk of regulatory rejection or costly remedial requirements.
-0.40The Rosen Law Firm has filed a securities class action lawsuit against Unicycive Therapeutics for allegedly making materially false and misleading statements between December 29, 2025, and June 29, 2026. — Securities litigation creates legal liability and overhead, signaling potential governance failures to investors.
-0.30Continue reading
5 related stories
Search tags
Which stocks this story touches
The company is facing a securities class action lawsuit alleging misleading statements regarding manufacturing compliance and FDA approval delays.
The company is mentioned as the subject of a securities class action notification from the Rosen Law Firm.
The company is mentioned as the subject of a securities class action notification from the Rosen Law Firm.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
